홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.0
  1. 홈
  2. /반응

1,2-Benzenediol, 4-(2-amino-1-hydroxyethyl)- → 3H-dopamine

HRID 48248
노트
인쇄 미리보기

반응식

HRID 48248 반응식
[CH:1]1[C:6]([CH:7](O)[CH2:8][NH2:9])=[CH:5][C:4]([OH:11])=[C:3]([OH:12])[CH:2]=1.[Na+].[Cl-].[Cl-].[K+].[Mg+2].[Cl-].[Cl-].[Cl-].[Cl-].[Ca+2].O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O.C([O-])(O)=O.[Na+].O=C1O[C@H]([C@H](CO)O)C(O)=C1O.C(N(CC(O)=O)CC(O)=O)CN(CC([O-])=O)CC([O-])=O.[Na+].[Na+].O=O>>[NH2:9][CH2:8][CH2:7][C:6]1[CH2:5][CH:4]([C:3](=[CH:2][CH:1]=1)[OH:12])[OH:11]
참가 물질반응 조건실험 절차후처리출처 및 근거반응 노트

참가 물질

11

반응물 10

HCID 9511,2-Benzenediol, 4-(2-amino-1-hydroxyethyl)-2회HCID 977OxygenHCID 4873Potassium ChlorideHCID 5234Sodium ChlorideHCID 79025Alpha-D-GlucoseHCID 516892Sodium BicarbonateHCID 5284359Calcium Chloride
HCID 5360315
Magnesium Chloride
HCID 13020083Ethylenediaminetetraacetic acid disodium salt
HCID 54670067L-Ascorbic Acid

생성물 1

HCID 573502783H-dopamine

반응 조건

온도
34 °C

실험 절차

Alkaloid effects on [3H]overflow from rat striatal slices preloaded with [3H]DA and hippocampal slices preloaded with [3H]NE were determined using modifications of a previously published method (Dwoskin and Zahniser, 1986). Briefly, coronal striatal or hippocampal slices (500 μm, 6-8 mg) were incubated in Krebs' buffer (118 mM NaCl, 4.7 mM KCl, 1.2 mM MgCl2, 1.0 mM NaH2PO4, 1.3 mM CaCl2, 11.1 mM α-D-glucose, 25 mM NaHCO3, 0.11 mM L-ascorbic acid and 4.0 mM disodium ethylenediaminetetraacetate; pH 7.4, and saturated with 95% O2/5% CO2) in a metabolic shaker at 34° C. for 30 min. Striatal or hippocampal slices were incubated in fresh buffer (6-8 slices/3 mL) containing 0.1 μM [3H]DA (3,4-[7-3H]-dihydroxyphenylethylamine; specific activity 28 Ci/mMol) or 0.1 μM [3H]NE (levo-[7-3H]-norepinephrine; specific activity 14.4 Ci/mMol), respectively, for an additional 30 min. After rinsing, each slice was transferred to a glass superfusion chamber maintained at 34° C. and was superfused at 1 mL/min with oxygenated Krebs' buffer containing pargyline (10 μM) and nomifensine (10 μL) or pargyline and desipramine (10 μL) in experiments assessing [3H]DA and [3H]NE overflow, respectively. After 60 min of superfusion, three 5-min samples (5 mL) were collected to determine basal [3H]outflow. After collection of the third basal sample, slices from an individual rat were superfused in the absence or presence of a single concentration of analog, which remained in the buffer until the end of the experiment. Each slice was exposed to only one concentration of analog. After 30 min, S(−)-nicotine (10 μM) was added to the buffer containing analog, and superfusion continued for an additional 60 min. These experiments utilized a repeated measures design, such that the analog concentration-effect was determined in both the absence and presence of S(−)-nicotine using striatal or hippocampal slices from a single rat. Additionally, one striatal or hippocampal slice was superfused in the absence of analog and constituted the control condition. At the end of the experiment, each slice was solubilized with TS-2. The pH and volume of the solubilized tissue samples were adjusted to those of the superfusate samples. Radioactivity in the superfusate and tissue samples was determined by liquid scintillation spectroscopy (Packard model B1600 TR Scintillation Counter, Downer's Grove, Ill.).

후처리

  1. washAfter rinsing
  2. additionbuffer containing pargyline (10 μM) and nomifensine (10 μL) or pargyline and desipramine (10 μL) in experiments
  3. customAfter 60 min of superfusion, three 5-min samples (5 mL) were collected
  4. customAfter collection of the third basal sample, slices from an individual rat
  5. concentrationwere superfused in the absence or presence of a single concentration of analog, which
  6. waitAfter 30 min
  7. additionS(−)-nicotine (10 μM) was added to the buffer containing analog, and superfusion
  8. waitcontinued for an additional 60 min
  9. concentrationsuch that the analog concentration-effect

출처 및 근거

ORD 기록
ord-6c29dcc89b6e4e3a96c3dcf0388e71ce
출처 데이터셋
uspto-grants-2004_03
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US06703406B2

반응 노트

불러오는 중…

이 페이지에서참가 물질반응 조건실험 절차후처리출처 및 근거반응 노트